Page last updated: 2024-09-05

phosphatidylcholines and Angiogenesis, Pathologic

phosphatidylcholines has been researched along with Angiogenesis, Pathologic in 13 studies

Research

Studies (13)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's7 (53.85)29.6817
2010's6 (46.15)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bursill, CA; Cheung, H; Ng, MKC; Nicholls, SJ; Ritchie, W; Solly, EL; Tan, JTM; Vanags, LZ; Wong, NKP1
Ali-Fehmi, R; Armaiz-Pena, GN; Baggerly, KA; Bar-Eli, M; Cooper, LJ; Ehsanipour, EA; Filant, J; Gharpure, KM; Haemmerle, M; Han, HD; Hatakeyama, H; Herbrich, SM; Huang, L; Hung, MC; Ivan, C; Kim, JH; Lee, JS; Lopez-Berestein, G; Maiti, SN; McGuire, MH; Nagaraja, AS; Olsen, C; Pecot, CV; Pham, E; Pradeep, S; Ram, PT; Rodriguez-Aguayo, C; Rupaimoole, R; Seviour, EG; Shen, F; Sood, AK; Tucker, S; Vidal-Anaya, V; Wu, SY; Yang, D; Zhang, M; Zhang, X1
Bottsford-Miller, JN; Dial, EJ; Dorniak, PL; Fang, D; Filant, J; Haemmerle, M; Hansen, JM; Hatakeyama, H; Hu, W; Huang, Y; Lichtenberger, LM; Lyons, Y; Pradeep, S; Previs, RA; Shen, F; Sood, AK; Taylor, M; Wagner, MJ1
Diakova, GB; Herbst, EB; Hossack, JA; Klibanov, AL; Mauldin, FW; Wang, S1
Ishida, T; Kiwada, H; Matsunaga, M; Moriyoshi, N; Nakamura, K; Suzuki, T; Tagami, T1
Inoue, Y; Matsubara, K; Ohkubo, T; Takahashi, K; Tsushima, T1
Fogelman, AM; Grijalva, V; Hama, S; Hassan, K; Mottahedeh, R; Navab, M; Ng, C; Reddy, ST; Wadleigh, DJ1
Apollonio, P; Bombardelli, E; Ferlini, C; Gallo, D; Giacomelli, S; Morazzoni, P; Prislei, S; Raspaglio, G; Riva, A; Scambia, G1
Bertini, I; Bianchini, F; Calorini, L; Colagrande, S; Fragai, M; Franchi, A; Gallo, O; Gavazzi, C; Luchinat, C1
Bucana, C; Chavez-Reyes, A; Deavers, MT; Landen, CN; Lopez-Berestein, G; Schmandt, R; Sood, AK1
Chavez-Reyes, A; Cole, SW; Coleman, RL; Gershenson, DM; Halder, J; Han, LY; Jennings, NB; Kamat, AA; Landen, CN; Lin, YG; Lopez-Berestein, G; Lutgendorf, SK; Merritt, WM; Schmandt, R; Sood, AK1
Aggarwal, BB; Diagaradjane, P; Gelovani, JG; Guha, S; Krishnan, S; Kunnumakkara, AB; Lopez-Berestein, G; Mehta, K; Sanguino, AM; Sood, AK; Verma, A1
Apollonio, P; Bombardelli, E; Distefano, M; Ferlini, C; Gallo, D; Giacomelli, S; Mancuso, S; Morazzoni, P; Riva, A; Scambia, G1

Other Studies

13 other study(ies) available for phosphatidylcholines and Angiogenesis, Pathologic

ArticleYear
Exploring the Roles of
    International journal of molecular sciences, 2018, Jun-28, Volume: 19, Issue:7

    Topics: Carcinogenesis; Cell Hypoxia; Cell Line; Endothelial Cells; Gene Expression Regulation; Gene Knockdown Techniques; Humans; Inflammation; Lipoproteins, HDL; Neovascularization, Pathologic; Nuclear Proteins; Phosphatidylcholines; Recombinant Proteins; Tumor Suppressor Proteins

2018
A miR-192-EGR1-HOXB9 regulatory network controls the angiogenic switch in cancer.
    Nature communications, 2016, Apr-04, Volume: 7

    Topics: Animals; Cell Line, Tumor; Down-Regulation; Early Growth Response Protein 1; Female; Gene Regulatory Networks; Genetic Therapy; Homeodomain Proteins; Humans; Kidney Neoplasms; Mice; MicroRNAs; Neovascularization, Pathologic; Ovarian Neoplasms; Phosphatidylcholines; Tumor Burden

2016
Antitumor and Antiangiogenic Effects of Aspirin-PC in Ovarian Cancer.
    Molecular cancer therapeutics, 2016, Volume: 15, Issue:12

    Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Aspirin; Biomarkers; Cell Line, Tumor; Cell Proliferation; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Humans; Hypoxia; Mice; Neovascularization, Pathologic; Ovarian Neoplasms; Phosphatidylcholines; Thromboxanes; Xenograft Model Antitumor Assays

2016
Ultra-Low-Dose Ultrasound Molecular Imaging for the Detection of Angiogenesis in a Mouse Murine Tumor Model: How Little Can We See?
    Investigative radiology, 2016, Volume: 51, Issue:12

    Topics: Adenocarcinoma; Animals; Contrast Media; Disease Models, Animal; Female; Mice; Mice, Inbred C57BL; Microbubbles; Molecular Imaging; Neovascularization, Pathologic; Phosphatidylcholines; Ultrasonography; Vascular Endothelial Growth Factor Receptor-2

2016
Anti-angiogenic therapy via cationic liposome-mediated systemic siRNA delivery.
    International journal of pharmaceutics, 2012, Jan-17, Volume: 422, Issue:1-2

    Topics: Air Sacs; Animals; Argonaute Proteins; Carcinoma, Lewis Lung; Cations; Cell Cycle Checkpoints; Cell Proliferation; Cholesterol; Ethanolamines; Genetic Therapy; Lipids; Liposomes; Male; Mice; Myristates; Neovascularization, Pathologic; Neovascularization, Physiologic; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols; RNA Interference; RNA, Small Interfering; Time Factors; Transfection; Tumor Burden

2012
Docosahexaenoic- and eicosapentaenoic acid-bound lysophospholipids are more effective in suppressing angiogenesis than conjugated docosahexaenoic acid.
    Journal of oleo science, 2012, Volume: 61, Issue:8

    Topics: Animals; Aorta; Cell Movement; Decapodiformes; Docosahexaenoic Acids; Eicosapentaenoic Acid; Human Umbilical Vein Endothelial Cells; Humans; In Vitro Techniques; Lysophosphatidylcholines; Lysophospholipids; Male; Neovascularization, Pathologic; Neovascularization, Physiologic; Phosphatidylcholines; Rats; Rats, Wistar; Sus scrofa

2012
Identification of genes induced by oxidized phospholipids in human aortic endothelial cells.
    Vascular pharmacology, 2002, Volume: 38, Issue:4

    Topics: Aorta, Thoracic; Blotting, Northern; Chemokines; Cloning, Molecular; DNA, Complementary; Endothelium, Vascular; Extracellular Matrix; Gene Expression Regulation; Growth Substances; Humans; In Vitro Techniques; Inflammation; Lipoproteins, LDL; Neovascularization, Pathologic; Nucleic Acid Hybridization; Oxidation-Reduction; Phosphatidylcholines; Phospholipids; RNA, Messenger; Signal Transduction; Transcriptional Activation

2002
Antitumour activity of the silybin-phosphatidylcholine complex, IdB 1016, against human ovarian cancer.
    European journal of cancer (Oxford, England : 1990), 2003, Volume: 39, Issue:16

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; DNA, Complementary; Drug Evaluation; Drug Screening Assays, Antitumor; Female; Humans; Mice; Mice, Nude; Neovascularization, Pathologic; Ovarian Neoplasms; Phosphatidylcholines; Silymarin; Vascular Endothelial Growth Factor A

2003
Persistent contrast enhancement by sterically stabilized paramagnetic liposomes in murine melanoma.
    Magnetic resonance in medicine, 2004, Volume: 52, Issue:3

    Topics: Animals; Contrast Media; Gadolinium DTPA; Immunohistochemistry; Liposomes; Magnetic Resonance Imaging; Melanoma; Mice; Neovascularization, Pathologic; Phosphatidylcholines; Phosphatidylethanolamines; Polyethylene Glycols

2004
Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery.
    Cancer research, 2005, Aug-01, Volume: 65, Issue:15

    Topics: Animals; Cell Line, Tumor; Down-Regulation; Female; Genetic Therapy; Humans; Liposomes; Mice; Mice, Nude; Neovascularization, Pathologic; Ovarian Neoplasms; Phosphatidylcholines; Receptor, EphA2; RNA, Small Interfering; Xenograft Model Antitumor Assays

2005
Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Aug-15, Volume: 12, Issue:16

    Topics: Animals; Apoptosis; Cell Proliferation; Down-Regulation; Female; Focal Adhesion Protein-Tyrosine Kinases; Humans; Liposomes; Mice; Mice, Nude; Neovascularization, Pathologic; Ovarian Neoplasms; Phosphatidylcholines; RNA, Small Interfering; Xenograft Model Antitumor Assays

2006
Therapeutic significance of elevated tissue transglutaminase expression in pancreatic cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Apr-15, Volume: 14, Issue:8

    Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Gene Silencing; GTP-Binding Proteins; Humans; Male; Mice; Neovascularization, Pathologic; Pancreatic Neoplasms; Phosphatidylcholines; Protein Glutamine gamma Glutamyltransferase 2; RNA, Small Interfering; Transglutaminases

2008
Silybin and its bioavailable phospholipid complex (IdB 1016) potentiate in vitro and in vivo the activity of cisplatin.
    Life sciences, 2002, Feb-08, Volume: 70, Issue:12

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cisplatin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Drug Synergism; Female; Mice; Mice, Nude; Neoplasms, Experimental; Neovascularization, Pathologic; Ovarian Neoplasms; Phosphatidylcholines; Silymarin; Tumor Cells, Cultured

2002